Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Novel fixed dose combination EHCV shows promise against chronic hepatitis C in clinical study

March 2, 2017

FDA accepts Dynavax's response to Heplisav-B complete response letter

March 1, 2017

Astellas and Affinivax enter worldwide partnership for MAPS vaccine targeting pneumococcus

March 1, 2017

WHO publishes list of antibiotic-resistant priority pathogens

March 1, 2017

EMA committee hands down positive opinion for 8-week regimen of Viekirax + Exviera

March 1, 2017

Arsanis signs license agreement with Adimab for rights to antibodies targeting RSV

Feb. 28, 2017

Bayer initiates phase I trial of BAY-1834845

Feb. 28, 2017

Finch Therapeutics enters collaboration with OpenBiome to develop FIN-403

Feb. 28, 2017

Phase III study of fusidic acid achieves primary endpoint in patients with ABSSSI

Feb. 27, 2017

Abivax reports discovery of molecules for treatment of dengue virus

Feb. 24, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...